We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.88T Turnover 6.4%
1-Year Est. Return 44.46%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+44.46%
3 Year Est. Return
+136.69%
5 Year Est. Return
+180.19%
10 Year Est. Return
+695.64%
AUM
$184B
AUM Growth
-$4.57B
Cap. Flow
-$8.49B
Cap. Flow %
-4.62%
Top 10 Hldgs %
15.06%
Holding
4,187
New
96
Increased
2,386
Reduced
984
Closed
127
Avg Time Held
2.5 years
Top 10 Avg Time Held
1.9 years
Top 20 Avg Time Held
2.2 years

Top Buys

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$216M
2
CHTR icon
Charter Communications
CHTR
+$192M
3
SLB icon
SLB Ltd
SLB
+$79.3M
4
IBM icon
IBM
IBM
+$70.2M
5
NWL icon
Newell Brands
NWL
+$67.5M

Sector Composition

Rank Sector Weight
1 Healthcare 14.87%
2 Technology 14.38%
3 Financials 13.98%
4 Industrials 10.32%
5 Consumer Discretionary 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
HBP
3676
DELISTED
Huttig Building Products, Inc.
HBP
$119K ﹤0.01%
+22,756
New +$108K
2016 Q2
0 quarters
ARLZ
3677
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$119K ﹤0.01%
36,144
-41,106
-53% -$155K
2016 Q1
1 quarter
VERU icon
3678
Veru
VERU
$39.2M
$117K ﹤0.01%
9,326
– –
2013 Q2
12 quarters
TST
3679
DELISTED
TheStreet, Inc.
TST
$117K ﹤0.01%
10,375
– –
2013 Q2
12 quarters
HGG
3680
DELISTED
hhgregg Inc.
HGG
$117K ﹤0.01%
66,396
– –
2013 Q2
12 quarters
GOGL icon
3681
DELISTED
Golden Ocean Group
GOGL
$116K ﹤0.01%
35,018
+20,500
+141% +$77.7K
2015 Q3
3 quarters
ATYR icon
3682
aTyr Pharma
ATYR
$17.1M
$116K ﹤0.01%
2,994
-359
-11% -$16.7K
2015 Q3
3 quarters
KTEC icon
3683
DELISTED
Key Technology Inc
KTEC
$116K ﹤0.01%
12,659
– –
2013 Q2
12 quarters
FCFP
3684
DELISTED
FIRST COMMUNITY FINANCIAL PARTNERS INC.
FCFP
$116K ﹤0.01%
+13,271
New +$118K
2016 Q2
0 quarters
DDC icon
3685
DELISTED
Dominion Diamond Corporation
DDC
$116K ﹤0.01%
13,200
-34,080
-72% -$364K
2015 Q3
3 quarters
NMR icon
3686
Nomura Holdings
NMR
$27B
$115K ﹤0.01%
33,027
+5,391
+20% +$22.5K
2013 Q2
12 quarters
PTE
3687
DELISTED
PolarityTE, Inc. Common Stock
PTE
$115K ﹤0.01%
1,105
– –
2014 Q2
8 quarters
OCRX
3688
DELISTED
Ocera Therapeutics, Inc.
OCRX
$115K ﹤0.01%
60,638
– –
2014 Q3
7 quarters
ICLN icon
3689
iShares Global Clean Energy ETF
ICLN
$2.11B
– –
0
– –
2016 Q2
0 quarters
IMI
3690
DELISTED
Intermolecular, Inc.
IMI
$114K ﹤0.01%
77,331
– –
2013 Q2
12 quarters
VNR
3691
DELISTED
Vanguard Natural Resources, LLC
VNR
$113K ﹤0.01%
81,294
+27,476
+51% +$41.6K
2013 Q2
12 quarters
DTRM
3692
DELISTED
Determine, Inc. Common Stock
DTRM
$112K ﹤0.01%
74,013
– –
2014 Q3
7 quarters
XWEL icon
3693
XWELL
XWEL
$7.32M
$111K ﹤0.01%
+49
New +$114K
2016 Q2
0 quarters
UQM
3694
DELISTED
UQM Technologies, Inc.
UQM
$111K ﹤0.01%
176,536
– –
2013 Q2
12 quarters
MXPT
3695
DELISTED
MaxPoint Interactive, Inc.
MXPT
$111K ﹤0.01%
10,329
-1,216
-11% -$10.9K
2015 Q2
4 quarters
OCSL icon
3696
Oaktree Specialty Lending
OCSL
$1.02B
$110K ﹤0.01%
7,626
-767
-9% -$11.7K
2016 Q1
1 quarter
DVCR
3697
DELISTED
Diversicare Healthcare Services Inc
DVCR
$110K ﹤0.01%
13,755
– –
2013 Q2
12 quarters
BEBE icon
3698
DELISTED
Bebe Stores Inc
BEBE
$109K ﹤0.01%
21,682
-2,435
-10% -$11.8K
2013 Q2
12 quarters
EVOK icon
3699
DELISTED
Evoke Pharma
EVOK
$108K ﹤0.01%
110
– –
2014 Q1
9 quarters
ALJJ
3700
DELISTED
ALJ Regional Holdings Inc
ALJJ
$108K ﹤0.01%
+21,764
New +$97K
2016 Q2
0 quarters

Similar funds

Geode Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, Geode Capital Management held 4,187 positions worth $184B, down 2.4% from $188B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Geode Capital Management withdrew a net $8.49B in Q2 2016, closing 127 positions and reducing 984 holdings. Its most notable exit was Affymetrix Inc, an estimated $7.53B position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Financials.

Against the trend, Geode Capital Management opened a new position in S&P Global worth $215M.

  • Geode Capital Management's largest Q2 2016 buy was S&P Global: 2,009,728 shares worth $215M.
  • Geode Capital Management added most to Charter Communications in Q2 2016, an estimated $192M increase.
  • Geode Capital Management's biggest Q2 2016 reduction was GE Aerospace, cutting an estimated $72.2M.
  • Geode Capital Management fully exited Affymetrix Inc in Q2 2016, selling an estimated $7.53B.
  • Geode Capital Management's ten largest holdings make up 15% of its $184B portfolio in Q2 2016.
  • Geode Capital Management opened 96 new positions and closed 127 in Q2 2016.
  • Geode Capital Management's portfolio value fell 2.4% quarter-over-quarter to $184B.

Based on Geode Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.